EPO Patents = 1

Trademarks = 3

Forward Citations = 74

where 'Filed Patents' based on already Granted Patents

where 'Inventors Filed' based on already Granted Patents

6 inventors (with patents filed for the assignee):

Jingrong Jean Cui (4 out of 44 patents)

Evan W Rogers (4 out of 44 patents)

Dayong Zhai (3 out of 21 patents)

4. Yishan Li (3 out of 10 patents)

5. Jane Ung (1 out of 18 patents)

6. Wei Deng (1 out of 13 patents)

4 patents: Sort by Forward Citations

1. 10316044 - Chiral diaryl macrocycles as modulators of protein kinases (2019-06-11),

2. 10294242 - Diaryl macrocycle polymorph (2019-05-21),

3. 10246466 - Diaryl macrocycles as modulators of protein kinases (2019-04-02),

4. 9714258 - Diaryl macrocycles as modulators of protein kinases (2017-07-25),

TP Therapeutics is a precision oncology company dedicated to identifying and rapidly advancing novel targets and therapies to address unmet medical needs in cancer. Their lead candidate, TPX-0022, is a potent and selective inhibitor of MET/CSF1R/ALK. The company is committed to improving outcomes for cancer patients through innovative targeted therapies.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 2 2025

4 Patents

#972 in San Diego, CA

#13,663 in California

#58,977 in US

San Diego, CA, United States of America

Tp Therapeutics, Inc.